# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Stiff Person Syndrome
- **MONDO ID:**  (if available)
- **Category:** Autoimmune

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Stiff Person Syndrome**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2025-12-16T18:46:32.336249

1. dalakas2023therapiesinstiffperson pages 2-3
2. maarad2024stiffpersonsyndrome pages 6-7
3. matsui2023prevalenceclinicalprofiles pages 2-3
4. wang2024expandingclinicalprofiles pages 1-2
5. pignolo2025rituximabinstiffperson pages 1-2
6. pignolo2025rituximabinstiffperson pages 6-6
7. matsui2023prevalenceclinicalprofiles pages 1-2
8. maarad2024stiffpersonsyndrome pages 5-6
9. maarad2024stiffpersonsyndrome pages 2-5
10. alex2025gadantibodyassociatedstiffpersonsyndrome pages 5-6
11. alex2025gadantibodyassociatedstiffpersonsyndrome pages 1-3
12. wang2024expandingclinicalprofiles pages 7-9
13. and
14. https://doi.org/10.1212/nxi.0000000000200109
15. https://doi.org/10.7759/cureus.67887
16. https://doi.org/10.1007/s44337-025-00321-w
17. https://doi.org/10.1007/s00415-023-12123-0
18. https://doi.org/10.1212/nxi.0000000000200165
19. https://doi.org/10.1007/s00415-025-13157-2
20. https://doi.org/10.1007/s00415-023-11777-0
21. https://doi.org/10.1212/nxi.0000000000200109,
22. https://doi.org/10.7759/cureus.67887,
23. https://doi.org/10.1007/s44337-025-00321-w,
24. https://doi.org/10.1007/s00415-023-12123-0,
25. https://doi.org/10.1212/nxi.0000000000200165,
26. https://doi.org/10.1007/s00415-025-13157-2,